Want to grow your business? Download your free roadmap today: coltivar.com/growth

When it comes to investing in real estate, you don’t always have to buy the building or land directly to be considered an investor. In fact, diversifying your portfolio in this asset class may start with buying stocks of REITs or other real estate investment companies. In this episode I talk with my brother Nate Coughran, EVP of Finance at Capital Square, about ways to make money in real estate. We dive into cap rates, using real estate as a hedge, market timing, and strategies to maximize returns while reducing risks. Join us to discover the pros and cons of real estate investing and how you can get started today. Visit www.byfiq.com for more episodes and resources to empower your financial life.

_______________________________________

Disclaimer:
The views expressed here are those of the individual Coltivar Group, LLC (“Coltivar”) personnel quoted and are not the views of Coltivar or its affiliates. Certain information contained in here has been obtained from third-party sources. While taken from sources believed to be reliable, Coltivar has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation.

This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendations. The Company is not affiliated with, nor does it receive compensation from, any specific security. Please see https://www.coltivar.com/privacy-policy-and-terms-of-use for additional important information.

LinkedIn | YouTube

coltivar.com

Does human genome editing cross a line?